NCT04431765

Brief Summary

This research aims to confirm that the therapeutic effect of EMDR is associated with changes in the interaction between cognitive function and emotional stimuli in PTSD patients compared to a controlled therapy in a randomized, single-blind study.On the other hand, this study aims to observe neuronal and cognitive correlates related to EMDR therapy compared to a control therapy. This investigation would improve the understanding of the mechanisms of action of the EMDR, still unknown to date.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2018

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 16, 2020

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

7.5 years

First QC Date

April 30, 2020

Last Update Submit

February 8, 2023

Conditions

Keywords

Eye Movement Information- Post-traumatic Stress Disorder

Outcome Measures

Primary Outcomes (12)

  • Post Traumatic Stress Scale-5 (PCL-5)

    The PCL-5 is a self-assessment consisting of 20 items that measures the 20 PTSD symptoms of the DSM-5. The wording of the PCL-5 items reflects both changes in existing symptoms and the addition of new symptoms in the DSM-5. The objectives of PCL-5 are numerous, such as monitoring changes in symptoms during and after treatment, screening individuals with PTSD, making an interim diagnosis of PTSD.

    Before the therapy begins, at day 0

  • Post Traumatic Stress Scale-5

    The PCL-5 is a self-assessment consisting of 20 items that measures the 20 PTSD symptoms of the DSM-5. The wording of the PCL-5 items reflects both changes in existing symptoms and the addition of new symptoms in the DSM-5. The objectives of PCL-5 are numerous, such as monitoring changes in symptoms during and after treatment, screening individuals with PTSD, making an interim diagnosis of PTSD.

    Within 3 weeks before the end of the therapy

  • State Trait Anxiety Inventory (STAI)

    The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis. The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic. Higher scores are positively correlated with higher levels of anxiety.

    Before the therapy begins, at day 0

  • State Trait Anxiety Inventory (STAI)

    The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis. The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic. Higher scores are positively correlated with higher levels of anxiety.

    Within 3 weeks before the end of the therapy

  • The Short Form (36) Health Survey (SF36)

    TheSF36isashortquestionnairewith36itemswhichmeasureeightmulti-itemvariables:physicalfunctioning(10items),socialfunctioning(twoitems),rolelimitationsduetophysicalproblems(fouritems),rolelimitationsduetoemotionalproblems(threeitems),mentalhealth(fiveitems),energyandvitality(fouritems),pain(twoitems),andgeneralperceptionofhealth(fiveitems).Foreachvariableitemscoresarecoded,summed,andtransformedontoascalefrom0(worstpossiblehealthstatemeasuredbythequestionnaire)to100(bestpossiblehealthstate).

    Before the therapy begins, at day 0

  • The Short Form (36) Health Survey (SF36)

    TheSF36isashortquestionnairewith36itemswhichmeasureeightmulti-itemvariables:physicalfunctioning(10items),socialfunctioning(twoitems),rolelimitationsduetophysicalproblems(fouritems),rolelimitationsduetoemotionalproblems(threeitems),mentalhealth(fiveitems),energyandvitality(fouritems),pain(twoitems),andgeneralperceptionofhealth(fiveitems).Foreachvariableitemscoresarecoded,summed,andtransformedontoascalefrom0(worstpossiblehealthstatemeasuredbythequestionnaire)to100(bestpossiblehealthstate).

    Within 3 weeks before the end of the therapy

  • Childhood Trauma Questionnaire (CTQ)

    The Childhood Trauma Questionnaire (CTQ) is a questionnaire developed by Bernstein et al. (1994) that includes 70 items with a Likert scale in five response choices (from 1 = "never true" to 5 = "very often true").

    Before the therapy begins, at day 0

  • Childhood Trauma Questionnaire (CTQ)

    The Childhood Trauma Questionnaire (CTQ) is a questionnaire developed by Bernstein et al. (1994) that includes 70 items with a Likert scale in five response choices (from 1 = "never true" to 5 = "very often true").

    Within 3 weeks before the end of the therapy

  • Clinician Administered PTSD Scale for DSM-5[CAPS-5])

    he CAPS-5 is a 30-item structured interview that can be used to: Make current (past month) diagnosis of PTSD,Make lifetime diagnosis of PTSD, Assess PTSD symptoms over the past week

    Before the therapy begins, at day 0

  • Clinician Administered PTSD Scale for DSM-5[CAPS-5])

    he CAPS-5 is a 30-item structured interview that can be used to: Make current (past month) diagnosis of PTSD,Make lifetime diagnosis of PTSD, Assess PTSD symptoms over the past week

    Within 3 weeks before the end of the therapy

  • Clinical Global Impression (CGI)

    The Clinical Global Impression (CGI) rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders

    Before the therapy begins, at day 0

  • Clinical Global Impression (CGI)

    The Clinical Global Impression (CGI) rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders

    Within 3 weeks before the end of the therapy

Study Arms (2)

Patient for Eye Movement desensitization Reprocessing therapy

ACTIVE COMPARATOR

Patient with post-traumatic Stress Disorder will receive Eye Movement Desensitization reprocessing therapy

Other: Eye Movement Desensitization Reprocessing therapy

patients for Trauma-Centred Cognitive and Behavioural Therapy

PLACEBO COMPARATOR

Patients with post-traumatic Stress Disorder will receive Trauma-Centred Cognitive and Behavioural Therapy

Behavioral: Trauma-Centred Cognitive and Behavioural Therapy

Interventions

The Eye Movement Desensitization Reprocessing therapy uses bi-alternating (right-left) sensory stimulation through eye movements. The patient follows the therapist's fingers from right to left in front of his eyes and also by auditory stimuli. The patient wears a helmet that alternately makes him hear a sound to the right, then to the left or touch the patient holds in his hands buzzers that alternately vibrate from right to left, or alternatively the therapist taps the patient's knees or the back of his hands.

Also known as: EMDR
Patient for Eye Movement desensitization Reprocessing therapy

A CBT is a short, scientifically validated therapy that focuses on the interactions between thoughts, emotions and behaviours. These therapies focus on the current problems of the person, while taking into account their historical causes. They help gradually overcome disabling symptoms and aim to strengthen adaptive behaviours. A CBT relies on different techniques that help the patient to identify the mechanisms at the origin of his difficulties, to experiment with new behaviors and thus to gradually come out of vicious circles that perpetuate and aggravate the psychic suffering.

Also known as: CBT
patients for Trauma-Centred Cognitive and Behavioural Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient diagnosed with PTSD according to DSM 5 criteria (APA 2013) related to a single traumatic event,
  • Aged 18 to 65 years,
  • Signed informed consent.
  • Patient with social security affiliation or State Medical Aid (AME)

You may not qualify if:

  • Neurological disorders
  • No other major psychiatric disorders than PTSD (DSM 5)
  • Severe and/or unstable somatic pathologies,
  • Patient not affiliated with social security,
  • Patient hospitalized under stress in psychiatric care at the decision of the state representative or in psychiatric care at the request of a third party,
  • Patient under guardianship,
  • Patient participating in parallel with other biomedical research,
  • Change of antidepressant during the last three months,
  • Patient not fluent in French
  • women of childbearing age without effective contraception or a positive pregnancy test,
  • patients carrying pacemakers or electrical or electronic devices, clips or metal prostheses,
  • subjects with neurological disorders, cerebral abnormalities or suffering from claustrophobia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ch Ville Evrard

Neuilly-sur-Marne, 93330, France

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Eye Movement Desensitization ReprocessingBehavior Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Desensitization, PsychologicPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Dominique Januel, MBBS

    CHVille Evrard

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rusheenthira THAVASEELAN, Msc

CONTACT

Youcef BENCHERIF, MSC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: In one hand, Patients with Post-traumatic Stress Disorder who will receive Eye Movement desensitization reprocessing therapy and in other hand patient with post-traumatic Stress Disorder who will receive Trauma-Centred Cognitive and Behavioural Therapy
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the clinical research department (psychiatrist)

Study Record Dates

First Submitted

April 30, 2020

First Posted

June 16, 2020

Study Start

July 2, 2018

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

February 10, 2023

Record last verified: 2023-02

Locations